Guidelines-based therapeutic strategies for controlling hypertension in non-controlled hypertensive patients followed by family physicians in primary health care in Portugal: the GPHT-PT study

References

• Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625–1636. doi:10.1016/S0140-6736(21)00590-0. Erratum in: lancet 2021; 397(10288):1884.
   PubMed Web of Science ®Google Scholar
• Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423. doi:10.1136/bmjopen-2013-003423.
   PubMed Web of Science ®Google Scholar
• Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies From 90 countries. Circulation. 2016;134(6):441–450. doi:10.1161/CIRCULATIONAHA.115.018912.
   PubMed Web of Science ®Google Scholar
• Polonia J, Martins L, Pinto F, et al. Prevalence awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. J Hypertens. 2014;32(6):1211–1221. doi:10.1097/HJH.0000000000000162.
   PubMed Web of Science ®Google Scholar
• Processo Assistencial Integrado do Risco Vascular no Adulto. Direção-Geral da Saúde (DGS), Departamento da Qualidade na Saúde 2014. ISBN 978-972-675-212-7. Available at: https://www.aenfermagemeasleis.pt/2015/01/05/processo-assistencial-integrado-do-risco-cardiovascular-no-adulto/amp/.
   Google Scholar
• Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization; 2021. ISBN-13: 978-92-4-003398-6ISBN-13: 978-92-4-003397-9
   Google Scholar
• Lopes E, Alarcão V, Simões R, et al. Hypertension control at the primary health care: a comparison among Portuguese natives and Portuguese speaking African coutries immigrants. Acta Med Port. 2016;29(3):193–204. doi:10.20344/amp.6714.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):e13–e115. doi:10.1161/HYP.0000000000000065.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Authors/Task Force Members., et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). J Hypertens. 2018;36(10):1953–2041. doi:10.1097/HJH.0000000000001940.
   PubMed Web of Science ®Google Scholar
• Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026.
   PubMed Web of Science ®Google Scholar
• Campbell NRC, Paccot Burnens M, Whelton PK, et al. 2021 World health organization guideline on pharmacological treatment of hypertension: policy implications for the region of the americas. Lancet Reg Health Am. 2022;9. doi:10.1016/j.lana.2022.100219.
   Google Scholar
• Roush GC, Buddharaju V, Ernst ME. Is chlorthalidone better than hydrochlorothiazide in reducing cardiovascular events in hypertensives? Curr Opin Cardiol. 2013;28(4):426–432. doi:10.1097/HCO.0b013e3283622075.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio JJ, Bhutani J, Lavie CJ, et al. Evidence-based diuretics: focus on chlorthalidone and indapamide. Future Cardiol. 2015;11(2):203–217. doi:10.2217/fca.14.83.
   PubMedGoogle Scholar
• Jamerson K, Weber MA, Bakris GL; ACCOMPLISH Trial Investigators., et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417–2428. doi:10.1056/NEJMoa0806182.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Palatini P, Parati G; European Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability., et al. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–1302. doi:10.1097/HJH.0000000000002843.
   PubMed Web of Science ®Google Scholar
• Egan BM, Sutherland SE, Rakotz M, et al. Improving hypertension control in primary care with the measure accurately, act rapidly, and partner with patients protocol. Hypertension. 2018;72(6):1320–1327. doi:10.1161/HYPERTENSIONAHA.118.11558.
   PubMed Web of Science ®Google Scholar
• Satish P, Khetan A, Raithatha S, et al. Standardizing hypertension management in a primary care setting in India through a protocol based model. Indian Heart J. 2019;71(5):375–380. doi:10.1016/j.ihj.2019.11.257.
   PubMedGoogle Scholar
• Pfeffer MA, McMurray JJ. Lessons in uncertainty and humility—clinical trials involving hypertension. N Engl J Med. 2016;375(18):1756–1766. doi:10.1056/NEJMra1510067.
   PubMed Web of Science ®Google Scholar
• Macedo ME, Lima MJ, Silva AO, et al. Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens. 2005;23(9):1661–1666. doi:10.1097/01.hjh.0000179908.51187.de.
   PubMed Web of Science ®Google Scholar
• Walsh JM, McDonald KM, Shojania KG, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44(7):646–657. doi:10.1097/01.mlr.0000220260.30768.32.
   PubMed Web of Science ®Google Scholar